Op werkdagen voor 23:00 besteld, morgen in huis Gratis verzending vanaf €20
010-4091959
Hematology-Oncology Clinical Questions
Hematology-Oncology Clinical Questions
Julie Rowe Meer over de auteurs
, , , , , , , , e.a.

Hematology-Oncology Clinical Questions
Specificaties
Paperback, blz. | Engels
McGraw-Hill Education | e druk, 2019
ISBN13: 9781260026627
Rubricering
Juridisch :
McGraw-Hill Education e druk, 2019 9781260026627
€ 102,27
In winkelwagen
Levertijd ongeveer 11 werkdagen
Gratis verzonden

Samenvatting

Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product.

A unique point-of-care guide to clinical hematology-oncology that answers the most frequently asked questions

Hematology-Oncology Clinical Questions is the single-best resource for quickly converting the most current data and research into practical, diagnostic real-time solutions. This unique book answers more than 60 of the clinical hematology-oncology questions most commonly asked of the authors during consultation. The content flow simulates the consultation process: Question…Data…Synthesis…Solution. 

The initial chapters prepare you with essential background fundamentals of hematology-oncology. Subsequent chapters are divided into tumor type, beginning with solid tumor types, and then hematological malignancies. Each chapter includes:

• Key Concepts
• The Clinical Scenario
• The Action Items
• Pearls

Hematology-Oncology Clinical Questions will prove to be a powerful tool to help learners from all points of the clinical spectrum understand the basic concepts of caring for a cancer patient.

Specificaties

ISBN13:9781260026627
Taal:Engels
Bindwijze:paperback
Uitgever:McGraw-Hill Education

Inhoudsopgave

<p><B><span>Table of Contents</SPAN></B></P><p><B></B>&nbsp;</P><p><B></B></P><p><span><SPAN>1.<span> </SPAN></SPAN></SPAN><span>CHEMOTHERAPY AGENTS –WILL INCLUDE A SUMMARY OF EACH TYPE BEFORE CLINICAL QUESTIONS</SPAN></P><p></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Cytotoxic</SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Targeted Agents </SPAN></P><p><span><SPAN>c.<span> </SPAN></SPAN></SPAN><span>Hormonal Agents</SPAN></P><p><span><SPAN>d.<span> </SPAN></SPAN></SPAN><span>Immunotherapy</SPAN></P><p></P><p><span><SPAN>2.<span> </SPAN></SPAN></SPAN><span>RADIATION THERAPY</SPAN></P><p></P><p><span><SPAN>3.<span> </SPAN></SPAN></SPAN><span>MOST COMMON HEME QUESTIONS</SPAN></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Anemia</SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Thrombocytopenia</SPAN></P><p><span><SPAN>c.<span> </SPAN></SPAN></SPAN><span>Thrombosis</SPAN></P><p><span><SPAN>d.<span> </SPAN></SPAN></SPAN><span>Transfusion reactions</SPAN></P><p></P><p><span><SPAN>4.<span> </SPAN></SPAN></SPAN><span>SCREENING </SPAN></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Breast cancer </SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Cervical </SPAN></P><p><span><SPAN>c.<span> </SPAN></SPAN></SPAN><span>Colon Cancer </SPAN></P><p><span><SPAN>d.<span> </SPAN></SPAN></SPAN><span>Prostate </SPAN></P><p><span><SPAN>e.<span> </SPAN></SPAN></SPAN><span>Lung Cancer </SPAN></P><p></P><p><span><SPAN>5.<span> </SPAN></SPAN></SPAN><span>BREAST CANCER </SPAN></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Non-invasive </SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Invasive </SPAN></P><p><span><SPAN>c.<span> </SPAN></SPAN></SPAN><span>Inflammatory breast cancer </SPAN></P><p><span><SPAN>d.<span> </SPAN></SPAN></SPAN><span>Phyllodes </SPAN></P><p><span><SPAN>e.<span> </SPAN></SPAN></SPAN><span>Paget’s </SPAN></P><p></P><p><span><SPAN>6.<span> </SPAN></SPAN></SPAN><span>HEAD AND NECK </SPAN></P><p></P><p><span><SPAN>7.<span> </SPAN></SPAN></SPAN><span>THYROID CARCINOMAS </SPAN></P><p></P><p><span><SPAN>8.<span> </SPAN></SPAN></SPAN><span>GI CANCER </SPAN></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Esophagus </SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Gastric/GEJ </SPAN></P><p><span><SPAN>c.<span> </SPAN></SPAN></SPAN><span>Colon </SPAN></P><p><span><SPAN>d.<span> </SPAN></SPAN></SPAN><span>Rectal </SPAN></P><p><span><SPAN>e.<span> </SPAN></SPAN></SPAN><span>Anus </SPAN></P><p><span><SPAN>f.<span> </SPAN></SPAN></SPAN><span>Pancreas </SPAN></P><p><span><SPAN>g.<span> </SPAN></SPAN></SPAN><span>Cholangiocarcinoma </SPAN></P><p><span><SPAN>h.<span> </SPAN></SPAN></SPAN><span>Hepatocellular Carcinoma </SPAN></P><p><span><SPAN>i.<span> </SPAN></SPAN></SPAN><span>Neuroendocrine tumors </SPAN></P><p></P><p><span><SPAN>9.<span> </SPAN></SPAN></SPAN><span>GU CANCER </SPAN></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Bladder </SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Kidney </SPAN></P><p><span><SPAN>c.<span> </SPAN></SPAN></SPAN><span>Prostate </SPAN></P><p><span><SPAN>d.<span> </SPAN></SPAN></SPAN><span>Testicular </SPAN></P><p></P><p><span><SPAN>10.<span> </SPAN></SPAN></SPAN><span>GYNECOLOGICAL MALIGNANCIES </SPAN></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Cervical </SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Endometrial</SPAN></P><p><span><SPAN>c.<span> </SPAN></SPAN></SPAN><span>Ovarian </SPAN></P><p><span><SPAN>d.<span> </SPAN></SPAN></SPAN><span>Uterine </SPAN></P><p></P><p><span><SPAN>11.<span> </SPAN></SPAN></SPAN><span>MELANOMAS </SPAN></P><p></P><p><span><SPAN>12.<span> </SPAN></SPAN></SPAN><span>THORACIC </SPAN></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Small cell lung cancer </SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Non-small cell lung cancer </SPAN></P><p></P><p><span><SPAN>13.<span> </SPAN></SPAN></SPAN><span>SARCOMAS </SPAN></P><p></P><p><span><SPAN>14.<span> </SPAN></SPAN></SPAN><span>OCCULT PRIMARY </SPAN></P><p></P><p><span><SPAN>15.<span> </SPAN></SPAN></SPAN><span>BASICS OF PATHOLOGY AND HEMATOLOGY</SPAN></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Bone Marrow, Flow Cytometry, Cytogenetics, Molecular testing.</SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Solid tumor pathology basics</SPAN></P><p></P><p><span><SPAN>16.<span> </SPAN></SPAN></SPAN><span>BASICS OF BONE MARROW TRANSPLANTATION</SPAN></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Types (Allo, Auto)</SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Indications</SPAN></P><p></P><p><span><SPAN>17.<span> </SPAN></SPAN></SPAN><span>LYMPHOMAS </SPAN></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Hodgkin’s Lymphoma </SPAN></P><p><span><SPAN>i.<span> </SPAN></SPAN></SPAN><span>Classical HL</SPAN></P><p><span><SPAN>ii.<span> </SPAN></SPAN></SPAN><span>Nodular lymphocyte-predominant HL</SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Non-Hodgkin’s Lymphoma </SPAN></P><p><span><SPAN>i.<span> </SPAN></SPAN></SPAN><span>B-cell NHL</SPAN></P><p><span><SPAN>a)<span> </SPAN></SPAN></SPAN><span>Diffuse large B-cell Lymphoma (DLBCL)</SPAN></P><p><span><SPAN>b)<span> </SPAN></SPAN></SPAN><span>Follicular Lymphoma</SPAN></P><p><span><SPAN>c)<span> </SPAN></SPAN></SPAN><span>Mantle Cell Lymphoma (MCL)</SPAN></P><p><span><SPAN>d)<span> </SPAN></SPAN></SPAN><span>Small Lymphocytic Lymphoma (SLL)</SPAN></P><p><span><SPAN>e)<span> </SPAN></SPAN></SPAN><span>Primary CNS Lymphoma</SPAN></P><p><span><SPAN>f)<span> </SPAN></SPAN></SPAN><span>Primary Mediastinal Lymphoma (PML)</SPAN></P><p><span><SPAN>g)<span> </SPAN></SPAN></SPAN><span>Burkitt Lymphoma (BL)</SPAN></P><p><span><SPAN>h)<span> </SPAN></SPAN></SPAN><span>Primary Effusion Lymphoma</SPAN></P><p><span><SPAN>i)<span> </SPAN></SPAN></SPAN><span>Double-hit Lymphoma</SPAN></P><p><span><SPAN>j)<span> </SPAN></SPAN></SPAN><span>Primary Effusion Lymphoma (PEL)</SPAN></P><p><span><SPAN>ii.<span> </SPAN></SPAN></SPAN><span>T-Cell NHL</SPAN></P><p><span><SPAN>a)<span> </SPAN></SPAN></SPAN><span>Peripheral T-cell Lymphoma (PTCL)</SPAN></P><p><span><SPAN>b)<span> </SPAN></SPAN></SPAN><span>Primary Cutaneous T-cell Lymphoma</SPAN></P><p><span><SPAN>c)<span> </SPAN></SPAN></SPAN><span>Anaplastic Large Cell Lymphoma (ALCL)</SPAN></P><p><span><SPAN>d)<span> </SPAN></SPAN></SPAN><span>Post-Transplant Lymphoproliferative </SPAN></P><p></P><p><span><SPAN>18.<span> </SPAN></SPAN></SPAN><span>LEUKEMIAS </SPAN></P><p><span><SPAN>a)<span> </SPAN></SPAN></SPAN><span>Acute Leukemias</SPAN></P><p><span><SPAN>i.<span> </SPAN></SPAN></SPAN><span>Acute Myeloid Leukemia (AML)</SPAN></P><p><span><SPAN>ii.<span> </SPAN></SPAN></SPAN><span>APL</SPAN></P><p><span><SPAN>i.<span> </SPAN></SPAN></SPAN><span>Acute Lymphoblastic Leukemia (ALL) </SPAN></P><p><span><SPAN>b)<span> </SPAN></SPAN></SPAN><span>Chronic Leukemias:</SPAN></P><p><span><SPAN>i.<span> </SPAN></SPAN></SPAN><span>Chronic Myeloid Leukemia (CML)</SPAN></P><p><span><SPAN>ii.<span> </SPAN></SPAN></SPAN><span>Chronic Lymphocytic Leukemia (CLL)</SPAN></P><p><span><SPAN>iii.<span> </SPAN></SPAN></SPAN><span>Hairy Cell Leukemia</SPAN></P><p></P><p><span><SPAN>19.<span> </SPAN></SPAN></SPAN><span>PLASMA CELL DISORDERS:</SPAN></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Monoclonal Gammopathy of Undetermined Significance (MGUS)</SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Multiple Myeloma (MM)</SPAN></P><p><span><SPAN>c.<span> </SPAN></SPAN></SPAN><span>Lymphoplasmacyctic Lymphoma (including Waldenstrom’s Macroglobulinemia)</SPAN></P><p><span><SPAN>d.<span> </SPAN></SPAN></SPAN><span>Solitary Plasmacytoma</SPAN></P><p><span><SPAN>e.<span> </SPAN></SPAN></SPAN><span>AL Amyloidosis</SPAN></P><p><span><SPAN>f.<span> </SPAN></SPAN></SPAN><span>POEMS Syndrome</SPAN></P><p></P><p><span><SPAN>20.<span> </SPAN></SPAN></SPAN><span>MYELOPROLIFERATIVE NEOPLASMS </SPAN></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Polycythemia Vera (PV)</SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Essential Thrombocythemia (ET)</SPAN></P><p><span><SPAN>c.<span> </SPAN></SPAN></SPAN><span>Primary Myelofibrosis (PMF)</SPAN></P><p><span><SPAN>d.<span> </SPAN></SPAN></SPAN><span>Systemic Mastocytosis (SM)</SPAN></P><p></P><p><span><SPAN>21.<span> </SPAN></SPAN></SPAN><span>MYELODYSPLASTIC SYNDROMES </SPAN></P><p></P><p><span><SPAN>22.<span> </SPAN></SPAN></SPAN><span>GUIDELINES FOR SUPPORTIVE CARE </SPAN></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Management of Side Effects of Chemotherapy</SPAN></P><p><span><SPAN>i.<span> </SPAN></SPAN></SPAN><span>Myelosuppression </SPAN></P><p><span><SPAN>ii.<span> </SPAN></SPAN></SPAN><span>Nausea</SPAN></P><p><span><SPAN>iii.<span> </SPAN></SPAN></SPAN><span>Vomiting</SPAN></P><p><span><SPAN>iv.<span> </SPAN></SPAN></SPAN><span>Diarrhea</SPAN></P><p><span><SPAN>v.<span> </SPAN></SPAN></SPAN><span>Mucositis</SPAN></P><p><span><SPAN>vi.<span> </SPAN></SPAN></SPAN><span>Anorexia, weight loss</SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Management of Cancer-related pain </SPAN></P><p><span><SPAN>c.<span> </SPAN></SPAN></SPAN><span>Management of Cachexia </SPAN></P><p></P><p><span><SPAN>23.<span> </SPAN></SPAN></SPAN><span>ONCOLOGIC EMERGENCIES </SPAN></P><p><span><SPAN>a.<span> </SPAN></SPAN></SPAN><span>Neutropenic Fever </SPAN></P><p><span><SPAN>b.<span> </SPAN></SPAN></SPAN><span>Spinal Cord Compression</SPAN></P><p><span><SPAN>c.<span> </SPAN></SPAN></SPAN><span>Tumor Lysis Syndrome </SPAN></P><p><span><SPAN>d.<span> </SPAN></SPAN></SPAN><span>Superior vena cava syndrome </SPAN></P><p><span><SPAN>e.<span> </SPAN></SPAN></SPAN><span>Hypercalcemia of malignancy </SPAN></P><p><span><SPAN>f.<span> </SPAN></SPAN></SPAN><span>Hyperleukocytosis and leukostasis</SPAN></P><p></P><p><span><SPAN>24.<span> </SPAN></SPAN></SPAN><span>GENETIC AND FAMILIAL ASSESSMENT
FOR FAMILIAL CANCER SYNDROMES</SPAN></P><p></P><p><span><SPAN>25.<span> </SPAN></SPAN></SPAN><span>END OF LIFE </SPAN></P><p></P>

Net verschenen

€ 102,27
Levertijd ongeveer 11 werkdagen
Gratis verzonden

Rubrieken

Uw cookie-instellingen
Deze website maakt gebruik van verschillende soorten cookies. Sommige cookies worden geplaatst door diensten van derden die op onze pagina's worden weergegeven. Om deze externe content te kunnen tonen is nodig dat u toestemming geeft voor het zetten van persoonlijke en marketingcookies. U kunt uw toestemming op elk moment wijzigen of intrekken. In onze cookieverklaring vindt u meer informatie.

    Personen

      Trefwoorden

        Hematology-Oncology Clinical Questions

        Recensiebeleid
        AI-book

        Wat is een AI-book?

        Een AI-book is niet een boek dat geschreven is door AI maar een boek dat verrijkt is met AI. Het maakt de inhoud van een boek interactief via WhatsApp, zodat je ermee kunt chatten. Zie het als een razend slimme assistent die het boek perfect begrijpt en er alles uit onthouden heeft. Jij kunt deze assistent alles vragen. Vraag bijvoorbeeld hoe je iets kunt toepassen op jouw persoonlijke situatie, om een korte samenvatting, of wat de belangrijkste inzichten zijn. AI-books zijn alleen te gebruiken via WhatsApp, je hoeft er geen aparte app voor te installeren.
        Meer informatie over AI-books

        ?

        Geef uw beoordeling

        Hematology-Oncology Clinical Questions

        Verwijder uw beoordeling